Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genetronics receives CE Mark approval for MedPulser solid tumor treatment

March 24, 1999

Aastrom receives SBIR grant for cord blood transplant program

March 22, 1999

Copernicus Therapeutics receives grant from NCI for novel gene therapy research

March 22, 1999

Vion seeks permission to begin clinical trials of TAPET vectors

March 19, 1999

Genzyme Transgenics and Millennium BioTherapeutics collaborate on transgenic biotherapeutics

March 19, 1999

Structural Bioinformatics achieves research milestone

March 19, 1999

Biovector collaborates with Chiron and Bayer on DNA delivery applications

March 19, 1999

Pasteur Merieux Connaught enters agreement to develop jet injectors for infuenza vaccines

March 18, 1999

GeneMedicine awarded two SBIR grants for gene therapy expression

March 17, 1999

Orchid and U. of Washington collaborate on genotyping technology

March 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...